Sequential immunization with vesicles prepared from heterologous Neisseria meningitidis strains elicits broadly protective serum antibodies to group B strains.
about
Crystal structure of Neisserial surface protein A (NspA), a conserved outer membrane protein with vaccine potentialThe meningococcal vaccine candidate neisserial surface protein A (NspA) binds to factor H and enhances meningococcal resistance to complementConformational epitopes recognized by protective anti-neisserial surface protein A antibodies.Inhibition of the alternative pathway of nonhuman infant complement by porin B2 contributes to virulence of Neisseria meningitidis in the infant rat modelReview of meningococcal group B vaccines.Immunospecific responses to bacterial elongation factor Tu during Burkholderia infection and immunization.Meningococcal factor H-binding protein variants expressed by epidemic capsular group A, W-135, and X strains from AfricaEffect of human serum on de-N-acetyl sialic acid epitope expression and antibody activity against N. meningitidis group BThe effect of human factor H on immunogenicity of meningococcal native outer membrane vesicle vaccines with over-expressed factor H binding protein.Membrane vesicles: an overlooked component of the matrices of biofilms.Binding of complement factor H to PorB3 and NspA enhances resistance of Neisseria meningitidis to anti-factor H binding protein bactericidal activity.Immunogenicity and safety of a combination of two serogroup B meningococcal outer membrane vesicle vaccines.Additive and synergistic bactericidal activity of antibodies directed against minor outer membrane proteins of Neisseria meningitidis.Towards an improved serogroup B Neisseria meningitidis vaccine.Development, characterization, and functional activity of a panel of specific monoclonal antibodies to inner core lipopolysaccharide epitopes in Neisseria meningitidisImpaired Immunogenicity of Meningococcal Neisserial Surface Protein A in Human Complement Factor H Transgenic Mice.Protective antibody responses elicited by a meningococcal outer membrane vesicle vaccine with overexpressed genome-derived neisserial antigen 1870Immunological evidence for functional rather than structural mimicry by a Shigella flexneri Y polysaccharide-mimetic peptideCellular Immune Responses in Humans Induced by Two Serogroup B Meningococcal Outer Membrane Vesicle Vaccines Given Separately and in CombinationVaccination with the recombinant major outer membrane protein elicits antibodies to the constant domains and induces cross-serovar protection against intranasal challenge with Chlamydia trachomatis.Meningococcal outer membrane vesicle vaccines derived from mutant strains engineered to express factor H binding proteins from antigenic variant groups 1 and 2Bactericidal antibody responses elicited by a meningococcal outer membrane vesicle vaccine with overexpressed factor H-binding protein and genetically attenuated endotoxinfH-dependent complement evasion by disease-causing meningococcal strains with absent fHbp genes or frameshift mutations.Expression of heterologous antigens in commensal Neisseria spp.: preservation of conformational epitopes with vaccine potential.Expression of the iron-activated nspA and secY genes in Neisseria meningitidis group B by Fur-dependent and -independent mechanisms.Immunogenicity of Nontypeable Haemophilus influenzae Outer Membrane Vesicles and Protective Ability in the Chinchilla Model of Otitis Media.Breadth and Duration of Meningococcal Serum Bactericidal Activity in Health Care Workers and Microbiologists Immunized with the MenB-FHbp Vaccine.Sequential Immunizations with heterosubtypic virus-like particles elicit cross protection against divergent influenza A viruses in mice.
P2860
Q27641060-8D6A638B-69ED-4520-96F6-A9658E416FAAQ28474974-7547524C-8275-4D16-A07B-E51C1AD96C44Q30164390-74E246DB-E449-4AE0-B9CD-C3A874628CB9Q33602953-D38AF157-768F-4A5F-BEB7-6B01FDFB30CCQ33646965-B21238A4-59A5-49AD-915E-C5BD3A6F17F8Q33778331-15DE02DB-50A9-40E8-AECF-9E34E5E2AF85Q34039044-78192712-DBBC-4B2C-9EA3-63EEA46394FDQ34076321-13E205B3-5B13-4F11-87E3-128C142F0B3FQ34270429-7074EFFD-9EB8-41B8-BB69-7C3FEDCED195Q34976712-387E8431-2B9A-417B-BB1C-B35FDB653A5CQ35187629-44A2CC0E-4C14-4E76-A6B5-CF02C64AD717Q36095135-D638A060-0103-4A22-87C8-F03401142164Q36313869-F80D1DF7-AD1A-4854-B537-47AD7DA04C32Q36327065-707D0300-B692-4B6D-BEB8-993B49413D64Q36455841-68E052AA-883D-447D-80D2-213372B8AAF4Q36513433-6B1AA4BB-8EAF-4FEF-966A-6DE5153A730FQ36638451-B6C5B1BD-9B19-489C-9C31-10CED70E022BQ36746947-AA495B51-2DD3-443D-BD3B-F04691430184Q36764403-0C5DE9E0-F889-45E8-90C1-923CEE815F8BQ36827004-47961EAC-D319-43A1-8C35-F51D258ECDCDQ37099232-76AF85FC-087F-44FB-AEC1-BC8B9894BD11Q37126987-354E69E0-A610-491D-87E9-B5EA77A48900Q37130358-2262E40B-8844-41D1-9DB3-A2B0FED11F23Q37582852-0AB5AB90-4F42-4C9C-9186-B9DE336897FBQ38307883-A2F2DEF8-A671-4382-BA3F-205E0A06E1E1Q38646104-1A037DAC-F16C-41DD-8183-88ED42D2B169Q40178578-DC64E272-9929-4B55-A282-C67E9D79EB4CQ52653233-D70DE65F-9AAC-4D39-B6CB-7CABD773DEB2
P2860
Sequential immunization with vesicles prepared from heterologous Neisseria meningitidis strains elicits broadly protective serum antibodies to group B strains.
description
2002 nî lūn-bûn
@nan
2002 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Sequential immunization with v ...... antibodies to group B strains.
@ast
Sequential immunization with v ...... antibodies to group B strains.
@en
Sequential immunization with v ...... antibodies to group B strains.
@nl
type
label
Sequential immunization with v ...... antibodies to group B strains.
@ast
Sequential immunization with v ...... antibodies to group B strains.
@en
Sequential immunization with v ...... antibodies to group B strains.
@nl
prefLabel
Sequential immunization with v ...... antibodies to group B strains.
@ast
Sequential immunization with v ...... antibodies to group B strains.
@en
Sequential immunization with v ...... antibodies to group B strains.
@nl
P2093
P2860
P921
P1476
Sequential immunization with v ...... antibodies to group B strains.
@en
P2093
Dan M Granoff
Gregory R Moe
Patricia Zuno-Mitchell
Samantha N Hammond
P2860
P304
P356
10.1128/IAI.70.11.6021-6031.2002
P407
P577
2002-11-01T00:00:00Z